Estepan Ian Michael

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 88% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Estepan Ian Michael's trades of Sarepta Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
224.11
Quantity 20,619
Value US$1,340,407
Transaction date
Proposed sale
Price
137.37
Quantity 5,985
Value US$822,130
Transaction date
Proposed sale
Price
127.81
Quantity 1,565
Value US$200,020
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-18 2025-12-16
S Sale
13,586 +21.6%
53.15
US$4,294,057 		13,586 +21.6% 53.15 US$4,294,057
2025-12-16 2025-12-16
PrS Proposed sale
20,619
224.11
US$1,340,407 		20,619 224.11 US$1,340,407
2024-09-03 2024-08-30
S Sale
4,607 -25.3%
24.32
US$2,631,296 		4,607 -25.3% 24.32 US$2,631,296
2024-08-30 2024-08-30
PrS Proposed sale
5,985
137.37
US$822,130 		5,985 137.37 US$822,130
2024-03-05 2024-03-01
S Sale
1,200 -3.0%
128.30
US$153,960 		1,200 -3.0% 128.30 US$153,960
2024-03-01 2024-03-01
PrS Proposed sale
1,565
127.81
US$200,020 		1,565 127.81 US$200,020